Mahdi Paryan

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Tyrosine Kinase

Long Noncoding Rna

Top Venues

Journal of cellular physiology

Hormone molecular biology and clinical investigation

Molecular biology reports

Endocrine, metabolic & immune disorders drug targets

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Anajafi, Mahdi Paryan, Amineh Khoshnazar, Masoud Soleimani, Samira Mohammadi-Yeganeh
miRNAs Delivery for Cancer-associated Fibroblasts' Activation and Drug Resistance in Cancer Microenvironment. Endocrine, metabolic & immune disorders drug targets (2023)
Shaghayegh Pishkari, Razie Hadavi, Ameneh Koochaki, Javad Razaviyan, Mahdi Paryan, Mehrdad Hashemi, Samira Mohammadi-Yeganeh
Assessment of AXL and mTOR genes expression in medullary thyroid carcinoma (MTC) cell line in relation with over expression of miR-144 and miR-34a. Hormone molecular biology and clinical investigation 42 (3) (2021)
Ali Noroozi-Aghideh, Zahra Kashani Khatib, Majid Naderi, Akbar Dorgalaleh, Marjan Yaghmaie, Mahdi Paryan, Shaban Alizadeh
Expression and CpG island methylation pattern of MMP-2 and MMP-9 genes in patients with congenital factor XIII deficiency and intracranial hemorrhage. Hematology (Amsterdam, Netherlands) 24 (1) (2020)
Hamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Razie Hadavi, Ameneh Koochaki, Mahdi Paryan
Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinoma. Molecular biology reports 47 (10) (2020)
Noushin Shabani, Sara Sheikholeslami, Mahdi Paryan, Marjan Zarif Yeganeh, Seyed Mohammad Tavangar, Fereidoun Azizi, Samira Mohammadi-Yeganeh, Mehdi Hedayati
An investigation on the expression of miRNAs including miR-144 and miR-34a in plasma samples of RET-positive and RET-negative medullar thyroid carcinoma patients. Journal of cellular physiology 235 (2) (2019)
Vida Pourteimoor, Mahdi Paryan, Samira Mohammadi-Yeganeh
microRNA as a systemic intervention in the specific breast cancer subtypes with C-MYC impacts; introducing subtype-based appraisal tool. Journal of cellular physiology 233 (8) (2018)